Stocks
Shire plcSHPG
NASDAQHealthcareBiotechnology$179.20+0.00%
A biopharmaceutical company focused on treatments for rare diseases and specialty conditions, with key franchises in immunology, hematology, neuroscience, and genetic disorders. Its portfolio historically included therapies such as Vyvanse for ADHD and a range of products targeting hereditary angioe...
Market Cap: $052W Range: $123.73 – $182.47
Congressional Interest in Shire plc (SHPG)
7 members of Congress have disclosed 21 trades in Shire plc (SHPG), a Healthcare company. The buy/sell breakdown shows 9 purchases versus 10 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
21
Unique Politicians
7
Buys
9
Sells
10
Who in Congress Is Trading SHPG?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-12-21 | Greg Gianforte | buy | $1K – $15K |
| 2018-05-10 | Greg Gianforte | sell | $100K – $250K |